TruScreen Stakeholder Newsletter

Truscreen Group Limited is pleased to provide a copy of its May 2021 Stakeholders Newsletter. This gives an update on Truscreen's performance and highlights key initiatives underway. CY2021 Q1 Key Activities: o Dual Listed on the ASX with a NZ$2 million capital raise o Appointment of Juliet Hull as Interim CEO o Appointment of Dr. Dexter Cheung to The Board o FY 31 March 2021 SUS sales volume +120% YOY o China market showing strong recovery o Commenced clinical evaluation in Saudi Arabia o Product registration submitted in 4 new markets in Central and Eastern Europe The Stakeholders Newsletter is available for viewing on the company website http://truscreen.com/investor-centre/newsletters/ ENDS For more information contact: Juliet Hull (CEO) juliethull@truscreen.com End CA:00371788 For:TRU Type:GENERAL Time:2021-05-06 13:09:49